Ozempic, Wegovy, Mounjaro - these weight loss meds are conversation starters for a reason.
GLP-1 medications have captured attention due to their efficacy for treating diabetes and chronic obesity, but there's much more to consider. At the current cost of these medications for treating obesity, how is our country going to treat all those that qualify? What are some ways that virtual care programs can help patients before, during and after taking these meds?
Omada's Chief Medical Officer Carolyn Bradner Jasik, MD provides an overview of GLP-1 medications and their history in the first part of a video blog series discussing Omada's clinical stance on GLP-1s.